Molecular Targets of Natural Compounds with Anti-Cancer Properties

Małgorzata Kubczak1,2, Aleksandra Szustka2, Małgorzata Rogalińska2

  • 1Department of General Biophysics, Faculty of Biology and Environmental Protection, University of Lodz, Pomorska 141/143, 90-237 Łódź, Poland.

Insights

Natural compounds from fruits and vegetables show promise as anti-cancer agents. These dietary components can influence cancer cell metabolism, proliferation, and epigenetic modifications, offering potential for improved cancer protection.

Area of Science:

  • Oncology
  • Natural Product Chemistry
  • Molecular Biology

Background:

  • Cancer remains a leading cause of death, with metastasis and drug resistance posing significant treatment challenges.
  • Cancer development involves deregulation of cellular pathways, including metabolism, cell cycle, apoptosis, angiogenesis, and epigenetics, influenced by the tumor microenvironment.

Purpose of the Study:

  • To review the anti-cancer properties of natural compounds.
  • To highlight the influence of natural agents on cancer cell metabolism, proliferation, signal transduction, and epigenetic modifications.

Main Methods:

  • Literature review of published research on natural compounds and their anti-cancer activities.
  • Analysis of studies investigating the effects of natural compounds on cancer cell pathways and molecular mechanisms.

Main Results:

  • Natural compounds, particularly polyphenols, flavonoids, stilbenes, carotenoids, and acetogenins from fruits and vegetables, exhibit anti-cancer potential in vitro and in vivo.
  • Natural compounds can modulate protein expression by affecting transcription factors and influence cellular responses, signaling, and epigenetic modifications.

Conclusions:

  • Natural compounds represent attractive alternatives to synthetic drugs, potentially offering similar anti-cancer efficacy with fewer side effects.
  • Dietary intake of natural compounds may contribute to anti-cancer protection by influencing key cancer-related cellular processes.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.9K
Targets for Drug Action: Overview01:26

Targets for Drug Action: Overview

Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
7.8K
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.2K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.0K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.2K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K